These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28294047)

  • 1. Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White?
    Cianciolo G; Galassi A; Capelli I; Schillaci R; La Manna G; Cozzolino M
    Curr Vasc Pharmacol; 2018 Jan; 16(2):143-156. PubMed ID: 28294047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.
    Yamada S; Giachelli CM
    Bone; 2017 Jul; 100():87-93. PubMed ID: 27847254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast Growth Factor 23: Mineral Metabolism and Beyond.
    Grabner A; Mazzaferro S; Cianciolo G; Krick S; Capelli I; Rotondi S; Ronco C; La Manna G; Faul C
    Contrib Nephrol; 2017; 190():83-95. PubMed ID: 28535521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FGF23 and Klotho system beyond mineral metabolism.
    Kuro-O M
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):64-69. PubMed ID: 27838783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular calcification.
    Massy ZA; Drüeke TB
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):405-12. PubMed ID: 23722182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.
    Fang Y; Ginsberg C; Sugatani T; Monier-Faugere MC; Malluche H; Hruska KA
    Kidney Int; 2014 Jan; 85(1):142-50. PubMed ID: 23884339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho/FGF23 Axis in CKD.
    Tsuchiya K; Nagano N; Nitta K
    Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Omata M; Fukagawa M; Kakuta T
    Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should We Consider the Cardiovascular System While Evaluating CKD-MBD?
    Rroji M; Figurek A; Spasovski G
    Toxins (Basel); 2020 Feb; 12(3):. PubMed ID: 32106499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
    Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
    Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the FGF23-Klotho axis.
    Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
    Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineral metabolism and cardiovascular disease in CKD.
    Fujii H; Joki N
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice.
    Han X; Cai C; Xiao Z; Quarles LD
    J Mol Cell Cardiol; 2020 Jan; 138():66-74. PubMed ID: 31758962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications.
    Salanova Villanueva L; Sánchez González C; Sánchez Tomero JA; Aguilera A; Ortega Junco E
    Nefrologia; 2016; 36(4):368-75. PubMed ID: 27118192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Klotho and vascular calcification].
    Matsui M; Saito Y
    Clin Calcium; 2016 Aug; 26(8):1157-64. PubMed ID: 27461499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New biomarkers of CKD-MBD].
    Pasquali M; Tartaglione L; Rotondi S
    G Ital Nefrol; 2016; 33(6):. PubMed ID: 28134398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease.
    Lunyera J; Scialla JJ
    Semin Nephrol; 2018 Nov; 38(6):542-558. PubMed ID: 30413250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF23 and Klotho in chronic kidney disease.
    Olauson H; Larsson TE
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):397-404. PubMed ID: 23666415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery calcification and cardiovascular disease in children with chronic kidney disease.
    Paoli S; Mitsnefes MM
    Curr Opin Pediatr; 2014 Apr; 26(2):193-7. PubMed ID: 24632542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.